Bangalore, June 26, 2008: The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals has received approval from the Canadian TPD (Therapeutic Products Directorate) for its ANDS (Abbreviated New Drug Submission) for Piperacillin and Tazobactam for Injection.

 

Orchid is a an integrated pharmaceutical Indian company with core competencies in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms as well as in drug discovery. From the very inception, Orchid has been investing aggressively for establishing modern research and manufacturing facilities aimed at global markets, thus emerging as a world-class pharmaceutical company covering the entire value chain from “Discovery to Delivery”.